incretin mimetics glp 1 agonists Clinical Focus on GLP-1 in Type 2 Diabetes Mellitus Incretin - an overview |
Description
Int J Mol Sci 2015
doi: 10.1016/j.cmet.2019.07.013 [DOI] [PMC free article] [PubMed] [Google Scholar] 138
Exenatide Reduces Tumor Necrosis Factor--induced Apoptosis in Cardiomyocytes by Alleviating Mitochondrial Dysfunction
Biochim Biophys Acta
2014;129(25 Suppl 2):S10238
Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: a model-based cost-effectiveness analysis using real-world data
